Disease/Infection News

RSS

TSRI scientists receive more than $13M to design effective HIV vaccine

A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)—which will play an essential role in the creation of any effective vaccine against HIV.

30 May 2014

Review on effects of pre-referral rectal artesunate for people with severe malaria

Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, conducted an independent review of the effects of pre-referral rectal artesunate for people with severe malaria, published in the Cochrane Library today.

30 May 2014

Lyme disease bacteria older than human race, says study

Lyme disease is a stealthy, often misdiagnosed disease that was only recognized about 40 years ago, but new discoveries of ticks fossilized in amber show that the bacteria which cause it may have been lurking around for 15 million years - long before any humans walked on Earth.

30 May 2014

New approach could lead to more effective HIV vaccine

Using a genetically modified form of the HIV virus, a team of University of Nebraska-Lincoln scientists has developed a promising new approach that could someday lead to a more effective HIV vaccine.

30 May 2014

TSRI scientists receive $13M grant to create effective vaccine against HIV

A team led by scientists at The Scripps Research Institute (TSRI) has received a grant of more than $13 million from the National Institute of Allergy and Infectious Disease of the National Institutes of Health to study antibodies to the human immunodeficiency virus (HIV)-which will play an essential role in the creation of any effective vaccine against HIV.

30 May 2014

Hand sanitizer powerful weapon against current measles outbreak

With measles cases in the U.S. at a 20-year high, it's more important than ever to keep your hands clean. Measles, caused by an airborne virus that's spread by breathing, coughing, and sneezing, can linger for up to two hours in the air or on surfaces.

30 May 2014

Biomedical scientists explore mechanisms of novel treatments for HCV

As new treatments for hepatitis C virus (HCV) are approved, biomedical scientists are exploring their mechanisms and what they reveal about the virus.

29 May 2014

Researchers explain how meningitis-causing bacteria evade body's immune system

Every once in a while in the U.S., bacterial meningitis seems to crop up out of nowhere, claiming a young life.

29 May 2014

Culture-based tests can help in accurate diagnosis of sore throats

Clinical guidelines conflict on testing teens and adults whose symptoms point to a possible strep throat.

29 May 2014

Testing for STI co-infections may improve HIV prevention in Africa

To maximize HIV prevention efforts in South Africa and perhaps the broader region, public health officials should consider testing for other sexually transmitted infections when they test for HIV, according to a new paper in the journal Sexually Transmitted Infections.

29 May 2014

Superbugs decrease among patients after adding UVD to cleaning regimen

Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

28 May 2014

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn’s disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.

28 May 2014

Scientists discover group of lymphocytes that protects against intracellular infection

The innate immune system recognizes infectious agents such as viruses and bacteria. A group of lymphocytes known as "innate lymphoid cells" or ILCs plays a central role in the defense of the human body against infective agents.

28 May 2014

WHO member states recognize psoriasis as chronic, non-communicable disease

At the 67th World Health Assembly, the WHO member states adopted a resolution on psoriasis, recognizing it as "a chronic, non-communicable, painful, disfiguring, and disabling disease for which there is no cure."

27 May 2014

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Inovio Pharmaceuticals, Inc. announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge.

27 May 2014

Employers to implement mandatory influenza vaccination policies for health care workers

Employers planning to implement mandatory influenza vaccination policies for health care workers need to understand the implications, according to an analysis published in CMAJ (Canadian Medical Association Journal).

27 May 2014

Lyme activists demand Congressional investigation of corruption within CDC, IDSA, and vaccine industry

Lyme activists, who have the Infectious Diseases Society of America headquarters surrounded and under siege, issued a call for a Congressional investigation of corruption within the CDC, IDSA, and the vaccine industry.

23 May 2014

World Health Assembly approves resolution on viral hepatitis and noncommunicable diseases

The World Health Assembly approved a resolution to improve the prevention, diagnosis and treatment of viral hepatitis and proposals to improve global coordination of efforts to address noncommunicable diseases like diabetes, cancers, heart disease and stroke. In addition, WHO's Director-General and the President of the Health Assembly presented 4 awards to leaders in public health.

23 May 2014

Growing resistance to antibiotics demands a coordinated global response, say experts

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, experts say.

23 May 2014

Study: Children born with HIV more likely to develop resistance to antiretroviral drugs than adults

Children born with HIV are far more likely to develop resistance to antiretroviral drugs than adults, according to a new Tulane University School of Medicine study.

23 May 2014

Disease/Infection News

TSRI scientists receive more than $13M to design effective HIV vaccine

Review on effects of pre-referral rectal artesunate for people with severe malaria

Lyme disease bacteria older than human race, says study

New approach could lead to more effective HIV vaccine

TSRI scientists receive $13M grant to create effective vaccine against HIV

Hand sanitizer powerful weapon against current measles outbreak

Biomedical scientists explore mechanisms of novel treatments for HCV

Researchers explain how meningitis-causing bacteria evade body's immune system

Culture-based tests can help in accurate diagnosis of sore throats

Testing for STI co-infections may improve HIV prevention in Africa

Superbugs decrease among patients after adding UVD to cleaning regimen

EC approves Takeda's Entyvio for treatment of adults with ulcerative colitis, Crohn’s disease

Scientists discover group of lymphocytes that protects against intracellular infection

WHO member states recognize psoriasis as chronic, non-communicable disease

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Employers to implement mandatory influenza vaccination policies for health care workers

Lyme activists demand Congressional investigation of corruption within CDC, IDSA, and vaccine industry

World Health Assembly approves resolution on viral hepatitis and noncommunicable diseases

Growing resistance to antibiotics demands a coordinated global response, say experts

Study: Children born with HIV more likely to develop resistance to antiretroviral drugs than adults

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News